Scammers are sending phishing emails disguised as digital event invitations, often spoofing legitimate sites like Punchbowl, ...
Samsung is closing the book on its proprietary texting platform this summer. After years of slowly phasing out the software in favor of a more unified experience, the company is finally pulling the ...
See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. President Donald Trump's threat to Iran on Tuesday, that "a whole ...
CONVENTIONAL WISDOM is forming quickly. Social-media use damages young people’s mental health and generative artificial intelligence is now eroding their ability to think. The anxiety is ...
Anthropic is trialling a feature that lets users send prompts to Claude from a smartphone. Claude will complete the task on its own on a person's computer. Anthropic's product underscores its push ...
BOSTON--(BUSINESS WIRE)--Leveragen, a Boston-based biotechnology company developing next-generation in vivo platforms for antibody discovery, today announced a collaboration agreement with Daiichi ...
CAMBRIDGE, U.K. — Before appearing on a screen in your hand or on your desk, this story and its photos existed as pulses of light, fired by lasers, that passed through strands of glass as fine as a ...
Flash floods are among the deadliest weather events in the world, killing more than 5,000 people each year. They’re also among the most difficult to predict. But Google thinks it has cracked that ...
Google has detailed the next phase of its 'Living Games' concept: using autonomous AI agents as a core component to support cloud-based game development. Announced at GDC Festival of Gaming, Google ...
Macworld explains the Apple MacBook Neo’s two USB-C ports have dramatically different speeds: one 10Gbps port for fast data transfer and displays, another 480Mbps port primarily for charging. Apple ...
There's new evidence that GLP-1 drugs like Ozempic can reduce the risk of addiction. A study of more than 600,000 veterans followed for up to three years found that those who started taking a GLP-1 ...